AQUA BIO TECHNOLOGY
TOTAL NUMBER OF VOTING RIGHTS AND CAPITAL
Aqua Bio Technology ASA: Share capital increase registered
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG, SOUTH AFRICA OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN Reference is made to the stock exchange announcement by Aqua Bio Technology ASA ("ABTEC" or the "Company") on 23 March 2026 regarding the final result of a subsequent offering of up to 800,000 new shares (the "Offer Shares") in the Company (the "Subsequent Offering"). Following the expiry of the subscription period in the Subsequent Offering, the Board of Directors resolved to allocate a total of 388,240 Offer Shares and to increase the Company's share capital with NOK 1,941,200 through the issuance of 388,240 Offer Shares, each with a par value of NOK 5.00. The share capital increase pertaining to the Subsequent Offering has now been registered with the Norwegian Register of Business Enterprises. The new share capital is NOK 78,080,875 divided by 15,616,175 shares, each with a par value of NOK 5.00. The Offer Shares are expected to be delivered to the VPS accounts of the subscribers today, and expected to be tradeable on 13 April 2026
Contacts Kristian Flaten CEO & CFO Aqua Bio Technology ASA
Phone: +47 9509 2322 Email: kf@aquabiotech.no
About Us Aqua Bio Technology ASA (ABTEC) is a technology and distribution group in skincare and nonfood. The group has distribution towards B2C and B2B, and offers freight, customs, and logistics services. The group also develops sustainable biotechnology for use in skincare products. Aqua Bio Technology is listed on Euronext Expand Oslo.
This notice is published by Kristian Flaten on the listed date and time.
This information has been submitted pursuant to the Securities Trading Act § 5-12 and MAR. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-04-10 11:40 CEST.